본문 바로가기

Lotte Biologics Signs Memorandum of Understanding to Attract Investment in Biopharmaceutical Mega Plant
  • Date Created : 2023-06-20
  • Number of Views : 122
(230620)롯데바이오로직스 시설투자 협약 체결(5814)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5816)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5817)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5819)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5820)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5821)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5814)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5816)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5817)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5819)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5820)-원본
(230620)롯데바이오로직스 시설투자 협약 체결(5821)-원본

June 20, 2023 (Tuesday) IFEZ signed a memorandum of understanding with Lotte Biologics to attract biopharmaceutical mega plants. This agreement calls for cooperation with Lotte Biologics to attract biopharmaceutical R&D and manufacturing facilities in Songdo International City District 11, secure business sites, and start construction of facilities. It announced plans to invest a total of $3 billion to build three biopharmaceutical R&D and manufacturing facilities. A total of 360,000 liters of antibody drug megapLANT will be built with 120,000 liters of antibody drug culture facilities per manufacturing facility, and a Bio-Venture Initiative (Bio-Venture Initiative) will also be operated.